At-Home Esketamine Study for Depression

Kadima Neuropsychiatry Institute is seeking participants for a study
investigating at-home esketamine for depression 📊

You may be eligible to participate if you:
– Are 18 years of age or older
– Have been diagnosed with clinical depression (Major Depressive Disorder)
– Are willing to attend some in-person visits at Kadima’s location in La Jolla,
with the dosing conducted from the comfort of your home.

Compensation for time and travel is provided.

Curious if you qualify? Complete our brief survey📝

Clexio Esketamine

Principal Investigator

Kadima’s Medical Director

Scroll to Top